P3HealthPartnersInc_NASDAQ_PIII_202310-K.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-KxANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2023oroTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the

2、transition period from toCommission file number:001-40033P3 Health Partners Inc.(Exact name of registrant as specified in its charter)Delaware85-2992794(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)2370 Corporate Circle Suite 300 Henderson,Nevada890

3、74(Address of principal executive offices)(Zip code)Registrants telephone number,including area code:(702)910-3950Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchangeon which registeredClass A common stock,par value$0.0001 per sharePIIIT

4、he Nasdaq Stock Market LLCWarrants,each whole warrant exercisable for oneshare of Class A common stock at an exercise priceof$11.50PIIIWThe Nasdaq Stock Market LLCSecurities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the registrant is a well-known seasoned issuer,as

5、 defined in Rule 405 of the Securities Act.Yes o No xIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes o No xIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)o

6、f the Securities Exchange Act of 1934 during the preceding 12 months(orfor such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes x No oIndicate by check mark whether the Registrant has submitted electron